TP53 has not previously been consistently reported as a prognostic marker for colorectal cancer in the curative setting, but very few large studies have included a sufficiently comprehensive molecular analysis of KRAS, BRAF, TP53, and MSI. This evidence concerns the gene TP53 and colorectal cancer.